ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0193

Factors Influencing Visit Preference in Patients with Rheumatic Diseases: A Qualitative Study

Kiara Aaron1, Catherine Nasrallah2, Lesley Jackson1, Sarah Goglin3, Diana Paez4, David Chae5, Faith Mugeta1, Norma Techarukpong1, Ellen McNeeley1, Gary Cutter1, kenneth saag1, Mary Margaretten4 and Maria Danila1, 1University of Alabama at Birmingham, Birmingham, AL, 2UCSF, San Francisco, 3University of California San Francisco, San Francisco, CA, 4University of California San Francisco, San Francisco, 5Tulane University School of Public Health and Tropical Medicine, New Orleans, LA

Meeting: ACR Convergence 2022

Keywords: Patient reported outcomes, Qualitative Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The COVID-19 pandemic has increased the use of telemedicine visits for patients living with rheumatic and musculoskeletal diseases (RMD). The factors that influence preferences of patients with RMD for telemedicine (vs). in-person visits are not well understood. The objective of this study, which is part of an ongoing multi-site clinical trial, was to examine factors influencing patients’ choices for the type of rheumatology visit.

Methods: During the recruitment process for a clinical trial comparing telemedicine vs. in-person rheumatology care (NCT04704544), we contacted patients with RMD by phone and asked them about their preference for their next visit type (telemedicine vs. in-person) and to specify their reasons for this preference. Patients’ answers to open-ended questions were analyzed thematically using the inductive method whereby two team members independently coded the data in excel with a third resolving any disagreements. Generated themes and sub-themes were contextualized into different levels of the socioecological framework. This project was approved by the UAB Institutional Review Board (IRB-300006553).

Results: We identified four levels of influence on patients’ preferences for the type of visit based on the socioecological framework: (i) individual influences; (ii) interpersonal influences; (iii) organizational/clinic level influences; (iv) structural influences (Figure). A total of 290 patients were contacted between March and May 2022 and 83 patients with mean age (SD) 56.8 (15.5) years, 22% men, 32.5% non-Hispanic Black expressed a preference for a visit type. Of these, 59 (71.1%) patients preferred an in-person visit. Of those who preferred an in-person visit, 43 (72.9%) did not give a specific reason. Reasons for preferring an in-person visit included: need for a physical examination, joint injections, or laboratory/imaging studies, privacy, personal convenience and comfort, as well as lack of familiarity with telemedicine (Figure 1). Of those who preferred a telemedicine visit (N=24), the majority (N=15, 62.5%) did not give a specific reason. Reasons for preferring a telemedicine visit included: COVID-19 fear, living/working too far from the clinic, cost of transportation, personal convenience, and prior commitments (Figure 1).

Conclusion: We found that almost a third of patients with RMD who received care at a large academic center in the Deep South were willing to have a telemedicine visit, although most desired an in-person visit due to organizational/clinic level influences which included need for ancillary services or procedures, convenience, and unfamiliarity with telemedicine. For those preferring telemedicine visits, we found that mostly individual-level influences, which included issues related to COVID fear, transportation cost, and convenience drove decisions. As this is an ongoing study, our next steps will include completion and analysis of the larger group of people who have specified their visit preference. Our findings suggest that continuing to offer telemedicine visits should be responsive to patients’ circumstances and needs.

Supporting image 1


Disclosures: K. Aaron, None; C. Nasrallah, None; L. Jackson, BHOF; S. Goglin, None; D. Paez, None; D. Chae, None; F. Mugeta, None; N. Techarukpong, None; E. McNeeley, None; G. Cutter, AI Therapeutics, AMO Pharma., Astra-Zeneca,, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring,, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, mmunic, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics, Prothena Biosciences, Novartis, Regeneron,, Sanofi-Aventis, Reata Pharmaceuticals, Alexion, Antisense Therapeutics, Biogen, Clinical Trial Solutions LLC, Genzyme, Genentech, GW Pharmaceuticals/Jazz, Klein-Buendel Incorporated, Merck/Serono, Osmotica Pharmaceuticals, Perception Neurosciences, Protalix Biotherapeutics,, Recursion/Cerexis Pharmaceuticals, Roche, SAB Biotherapeutics; k. saag, Horizon Therapeutics, SOBI, Shanton, AbbVie/Abbott; M. Margaretten, None; M. Danila, UCB, Pfizer.

To cite this abstract in AMA style:

Aaron K, Nasrallah C, Jackson L, Goglin S, Paez D, Chae D, Mugeta F, Techarukpong N, McNeeley E, Cutter G, saag k, Margaretten M, Danila M. Factors Influencing Visit Preference in Patients with Rheumatic Diseases: A Qualitative Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/factors-influencing-visit-preference-in-patients-with-rheumatic-diseases-a-qualitative-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-influencing-visit-preference-in-patients-with-rheumatic-diseases-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology